secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001753926-25-001602
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharmaceuticals CMO and Board Member Michael Chancellor to retire effective Dec 4, 2025
--------------------------------------------------------------------------------

- Dr. Michael Chancellor notified intention to retire as Chief Medical Officer and Board member.
- Retirement effective December 4, 2025; no disagreement with company cited.
- Dr. Chancellor's departure planned and not due to policy or operational disputes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625001602/0001753926-25-001602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392625001602/g084974_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-001602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer